Experimental determination of breast skin dose using volumetric modulated arc therapy and field-in-field treatment techniques

IF 0.3 Q4 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Journal of Radiotherapy in Practice Pub Date : 2022-10-03 DOI:10.1017/S1460396922000292
Ana María Cardona-Maya, J. A. Rojas-López, A. Germanier, P. Murina, D. Venencia
{"title":"Experimental determination of breast skin dose using volumetric modulated arc therapy and field-in-field treatment techniques","authors":"Ana María Cardona-Maya, J. A. Rojas-López, A. Germanier, P. Murina, D. Venencia","doi":"10.1017/S1460396922000292","DOIUrl":null,"url":null,"abstract":"Abstract Introduction: The use of volumetric modulated arc therapy (VMAT) on the breast has several dosimetric advantages but its impact on skin dose should be evaluated and compared to well-established treatment techniques using tangential fields. The aim of this work is to contrast the skin dose for VMAT and field-in-field (FIF) and to estimate the magnitude of the skin dose involved. Method: The skin dose was measured, without build-up, using thermoluminescent dosimeter (TLD) and optically stimulated luminescence dosimeter (OSLD) in breast radiotherapy by an in-house anthropomorphic phantom. Two different treatment techniques were used: FIF and VMAT, based on the planning strategy proposed by Nicolini et al. The dose levels were 4300 cGy, 4600 cGy and 5600 cGy in 20 fractions. In vivo dosimetry with TLD for VMAT was performed for different breast sizes in the same locations as phantom measurements. Results: The ipsilateral phantom breast skin dose using both treatment techniques was equivalent. TLD measured doses by the VMAT technique were up to 5% higher than OSLD, although they agree if we consider the geometry uncertainty of the TLD. In accordance with in vivo dosimetry, the mean dose of the ipsilateral breast skin was 62 ± 6% (51%, 75%) relative to the prescribed dose, regardless of the breast size for the volumes considered with this small population (n = 9) as shown by Mann–Whitney U-test (Z = 1·9, 95% confidence). The uncertainty expected in this region due to geometry (volume) changes is up to 9% higher for volumes from 225·9 cc to 968·8 cc. According to the treatment techniques and in vivo dosimetry, the contralateral breast skin dose was 1·0% in FIF and 2·5% in VMAT concerning the prescribed dose. Conclusion: There is no difference in skin dosimetry between VMAT and FIF techniques on the ipsilateral breast. It provides useful support for the use of VMAT as a planning technique for breast irradiation. The work describes the importance of quantifying potential differences in skin dosimetry.","PeriodicalId":44597,"journal":{"name":"Journal of Radiotherapy in Practice","volume":null,"pages":null},"PeriodicalIF":0.3000,"publicationDate":"2022-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Radiotherapy in Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1017/S1460396922000292","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0

Abstract

Abstract Introduction: The use of volumetric modulated arc therapy (VMAT) on the breast has several dosimetric advantages but its impact on skin dose should be evaluated and compared to well-established treatment techniques using tangential fields. The aim of this work is to contrast the skin dose for VMAT and field-in-field (FIF) and to estimate the magnitude of the skin dose involved. Method: The skin dose was measured, without build-up, using thermoluminescent dosimeter (TLD) and optically stimulated luminescence dosimeter (OSLD) in breast radiotherapy by an in-house anthropomorphic phantom. Two different treatment techniques were used: FIF and VMAT, based on the planning strategy proposed by Nicolini et al. The dose levels were 4300 cGy, 4600 cGy and 5600 cGy in 20 fractions. In vivo dosimetry with TLD for VMAT was performed for different breast sizes in the same locations as phantom measurements. Results: The ipsilateral phantom breast skin dose using both treatment techniques was equivalent. TLD measured doses by the VMAT technique were up to 5% higher than OSLD, although they agree if we consider the geometry uncertainty of the TLD. In accordance with in vivo dosimetry, the mean dose of the ipsilateral breast skin was 62 ± 6% (51%, 75%) relative to the prescribed dose, regardless of the breast size for the volumes considered with this small population (n = 9) as shown by Mann–Whitney U-test (Z = 1·9, 95% confidence). The uncertainty expected in this region due to geometry (volume) changes is up to 9% higher for volumes from 225·9 cc to 968·8 cc. According to the treatment techniques and in vivo dosimetry, the contralateral breast skin dose was 1·0% in FIF and 2·5% in VMAT concerning the prescribed dose. Conclusion: There is no difference in skin dosimetry between VMAT and FIF techniques on the ipsilateral breast. It provides useful support for the use of VMAT as a planning technique for breast irradiation. The work describes the importance of quantifying potential differences in skin dosimetry.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
体积调制电弧疗法和场中治疗技术测定乳腺皮肤剂量的实验研究
摘要简介:在乳腺上使用体积调制电弧疗法(VMAT)有几个剂量测量优势,但应评估其对皮肤剂量的影响,并将其与使用切向场的成熟治疗技术进行比较。这项工作的目的是对比VMAT和场中(FIF)的皮肤剂量,并估计所涉及的皮肤剂量的大小。方法:使用热致发光剂量计(TLD)和光刺激发光剂量计(OSLD),通过内部拟人体模测量乳腺放射治疗中的皮肤剂量,不产生累积。根据Nicolini等人提出的计划策略,使用了两种不同的治疗技术:FIF和VMAT。20个部分的剂量水平分别为4300 cGy、4600 cGy和5600 cGy。在与体模测量相同的位置,对不同乳房尺寸的VMAT进行TLD体内剂量测定。结果:使用两种治疗技术的同侧体模乳腺皮肤剂量相等。VMAT技术测得的TLD剂量比OSLD高出5%,尽管如果我们考虑TLD的几何不确定性,它们是一致的。根据体内剂量测定,同侧乳腺皮肤的平均剂量相对于规定剂量为62±6%(51%,75%),而不考虑这个小群体(n=9)体积的乳房大小,如Mann–Whitney U型检验(Z=1.9,95%置信度)所示。对于225.9立方厘米至968.8立方厘米的体积,由于几何形状(体积)变化,该区域的预期不确定性高达9%。根据治疗技术和体内剂量测定,FIF中对侧乳腺皮肤剂量为1.0%,VMAT中规定剂量的对侧乳腺皮肤剂量为2.5%。结论:VMAT和FIF技术在同侧乳腺的皮肤剂量测定上没有差异。它为VMAT作为乳腺照射计划技术的使用提供了有用的支持。这项工作描述了量化皮肤剂量测定中潜在差异的重要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Radiotherapy in Practice
Journal of Radiotherapy in Practice RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING-
CiteScore
0.80
自引率
0.00%
发文量
36
期刊介绍: Journal of Radiotherapy in Practice is a peer-reviewed journal covering all of the current modalities specific to clinical oncology and radiotherapy. The journal aims to publish research from a wide range of styles and encourage debate and the exchange of information and opinion from within the field of radiotherapy practice and clinical oncology. The journal also aims to encourage technical evaluations and case studies as well as equipment reviews that will be of interest to an international radiotherapy audience.
期刊最新文献
Wobbling nature of gamma passing rate as a function of calibration field sizes in patient-specific quality assurance Secondary fragmentation and relative biological effectiveness (RBE) study using Bridge SOI microdosimeter: Monte Carlo simulation Keratin-based topical cream for radiation dermatitis during head and neck radiotherapy: a randomised, open-label pilot study. Single catheter 3d volume based hybrid inverse planning optimization in IVBT can improve organ sparing – CORRIGENDUM Dosimetric case study of 3-D FiF vs. VMAT techniques in the treatment of H/N tumour
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1